4/A//SEC Filing
Wirostko Barbara 4/A
Accession 0001144204-18-034065
CIK 0001372514other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:32 PM ET
Size
8.7 KB
Accession
0001144204-18-034065
Insider Transaction Report
Form 4/AAmended
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Common Stock
2018-06-07$0.52/sh+9,600$4,992→ 249,997 total - Award
Common Stock
2018-06-08$0.54/sh+7,000$3,780→ 59,915 total(indirect: By Spouse) - Award
Common Stock
2018-06-07$0.52/sh+2,215$1,152→ 52,915 total(indirect: By Spouse)
Footnotes (1)
- [F1]The Form 4 previously filed on June 11, 2018 inadvertently misclassified the 2,215 shares purchased on June 7, 2018 and 7,000 shares purchased on June 8, 2018 as being beneficially owned directly by the reporting person instead of indirectly, and inadvertently omitted the purchase of 9,600 shares by the reporting person on June 7, 2018, which are beneficially owned directly. This amendment corrects that error to add the omitted transaction from June 7, 2018 and to reflect the correct number of shares beneficially owned by the reporting person, both directly and indirectly, after the reported transaction.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001669087
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:32 PM ET
- Size
- 8.7 KB